Republicans in Congress are pushing to make DTC cash drug purchases more attractive by requiring insurers to count that spending toward deductibles and out-of-pocket limits, Axios reports
- The change would address a key drawback for insured patients, whose cash payments currently do not help them reach the point where insurance covers more of their healthcare costs, Axios says
Context
This proposed change in Congress to count DTC cash drug purchases towards deductibles and out-of-pocket limits could significantly alter the financial landscape for insured patients, making medications more accessible. By addressing the current drawbacks, this policy may enhance patient spending power and could impact insurance group profitability and stock performance in the sector.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#EU SESSION#INSURANCE#INSURANCE (GROUP)#GLOBAL NEWS